UPDATE 2-WuXi Biologics prices HK IPO at top as investors seek growth business

HONG KONG, June 6 WuXi Biologics (Cayman) Inc priced its Hong Kong IPO at the top of expectations on Tuesday, raising $511 million in the largest new listing in the Asian financial hub in 2017, as investors jostled for a piece of the fast-growing business.
( read original story …)